BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3702685)

  • 21. The use of mixed-mode ion-exchange solid phase extraction to characterize pharmaceutical drug degradation.
    Landis MS
    J Pharm Biomed Anal; 2007 Sep; 44(5):1029-39. PubMed ID: 17553650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotinamide-adenine dinucleotide-specific isocitrate dehydrogenase from pea mitochondria. Purification and properties.
    Cox GF; Davies DD
    Biochem J; 1967 Nov; 105(2):729-34. PubMed ID: 4296325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of 3-aminopyridine 1,N6-ethenoadenine dinucleotide and 3-aminopyridine 1,N6-ethenoadenine dinucleotide phosphate.
    Anderson BM; Anderson CD
    Methods Enzymol; 1986; 122():156-61. PubMed ID: 3010032
    [No Abstract]   [Full Text] [Related]  

  • 24. Nucleotide modification, a radical mechanism of oxidative toxicity.
    Bernofsky C; O'Dea SW
    Free Radic Res Commun; 1986; 2(3):129-36. PubMed ID: 2850269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-sample preparation for simultaneous cellular redox and energy state determination.
    Lazzarino G; Amorini AM; Fazzina G; Vagnozzi R; Signoretti S; Donzelli S; Di Stasio E; Giardina B; Tavazzi B
    Anal Biochem; 2003 Nov; 322(1):51-9. PubMed ID: 14705780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonenzymatic reduction of benzo(a)pyrene diol-epoxides to trihydroxypentahydrobenzo(a)pyrenes by reduced nicotinamide adenine dinucleotide phosphate.
    Yang SK; Gelboin HV
    Cancer Res; 1976 Nov; 36(11 Pt 1):4185-9. PubMed ID: 10078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification, analysis, and preservation of reduced nicotinamide adenine dinucleotide 2'-phosphate.
    Markham KA; Sikorski RS; Kohen A
    Anal Biochem; 2003 Nov; 322(1):26-32. PubMed ID: 14705776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micropreparative ion exchange high performance liquid chromatography: applications to microsequence analysis.
    Nice EC; Fabri L; Hammacher A; Andersson K; Hellman U
    Biomed Chromatogr; 1993; 7(2):104-11. PubMed ID: 8485372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination, purification, and characterization of alpha-NADH.
    Klemm A; Steiner T; Cumme GA; Horn A
    Anal Biochem; 1993 Aug; 212(2):375-80. PubMed ID: 8214579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flagyl and reduced nicotinamide adenine dinucleotide.
    Coombs GH; Rabin BR
    FEBS Lett; 1974 May; 42(1):105-7. PubMed ID: 4368731
    [No Abstract]   [Full Text] [Related]  

  • 31. Light-dependent reduction of nicotinamide adenine dinucleotide phosphate by chromatophores of Rhodopseudomonas spheroides.
    Orlando JA
    Arch Biochem Biophys; 1968 Mar; 124(1):413-7. PubMed ID: 4385595
    [No Abstract]   [Full Text] [Related]  

  • 32. Protein binding of nicotinamide adenine dinucleotide and regulation of nicotinamide adenine dinucleotide glycohydrolase activity in homogenates of rabbit skeletal muscle.
    Bernofsky C; Pankow M
    Arch Biochem Biophys; 1973 May; 156(1):143-53. PubMed ID: 4354231
    [No Abstract]   [Full Text] [Related]  

  • 33. Nicotinamide 3,N4-ethenocytosine dinucleotide, an analog of nicotinamide adenine dinucleotide. Synthesis and enzyme studies.
    Greenfield JC; Leonard NJ; Gumport RI
    Biochemistry; 1975 Feb; 14(4):698-706. PubMed ID: 234741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of 3-chloroacetylpyridine adenine dinucleotide: an alkylating analogue of NAD+.
    Biellmann JF; Branlant G; Foucaud BY; Jung MJ
    FEBS Lett; 1974 Mar; 40(1):29-32. PubMed ID: 4369036
    [No Abstract]   [Full Text] [Related]  

  • 35. High-performance liquid chromatography separation of some NAD+ derivatives suitable for covalent binding.
    Kahle V; Kovár J; Simek K; Tesarik K
    Anal Biochem; 1981 Aug; 115(2):245-9. PubMed ID: 7304956
    [No Abstract]   [Full Text] [Related]  

  • 36. SEPARATION AND PURIFICATION OF OXIDIZED AND REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDES.
    SILVERSTEIN E
    Anal Biochem; 1965 Aug; 12():199-212. PubMed ID: 14340010
    [No Abstract]   [Full Text] [Related]  

  • 37. Peculiarities of gradient ion-exchange high-performance liquid chromatography of proteins.
    Dubinina NI; Kurenbin OI; Tennikova TB
    J Chromatogr A; 1996 Nov; 753(2):217-25. PubMed ID: 8962510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatography: effective protein purification by various chromatographic modes.
    Chicz RM; Regnier FE
    Methods Enzymol; 1990; 182():392-421. PubMed ID: 2314251
    [No Abstract]   [Full Text] [Related]  

  • 39. Glyceraldehyde-3-phosphate dehydrogenase catalyzed hydration of the 5-6 double bond of reduced beta-nicotinamide adenine dinucleotide (betaNADH). Formation of beta-6-hydroxy-1,4,5,6-tetrahydronicotinamide adenine dinucleotide.
    Oppenheimer NJ; Kaplan NO
    Biochemistry; 1974 Nov; 13(23):4685-94. PubMed ID: 4371815
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct determination of D-[U-14C] glucaric acid in urine by ion-exchange high-performance liquid chromatography.
    Walters DG; Lake BG; Bayley D; Cottrell RC
    J Chromatogr; 1983 Aug; 276(1):163-8. PubMed ID: 6423654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.